Fourpath Capital Management, Llc
Source: SEC Form 13F · as of Mar 2026Fourpath Capital Management, Llc holds 12 biotech & pharma companies tracked by BioSniper, totaling $34.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$34.8M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 13,623 | $12.5M |
| JNJJOHNSON & JOHNSON | 35,307 | $8.6M |
| MCKMcKesson Corporation | 5,248 | $4.5M |
| MRKMerck & Co., Inc. | 18,420 | $2.2M |
| PFEPFIZER INC | 44,715 | $1.3M |
| SNYSanofi | 25,962 | $1.3M |
| ABBVAbbVie Inc. | 5,401 | $1.2M |
| PMPhilip Morris International Inc | 6,942 | $1.1M |
| AMGNAMGEN INC | 2,194 | $772K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,687 | $753K |
| BMYBRISTOL MYERS SQUIBB CO | 5,383 | $326K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 691 | $229K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.